Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
The American Surgeon: In Defense of Industry-Physician Relationships
As the number of restrictions on physicians working with industry continue to grow, and the places where policies prohibit…
The Miracle of Insulin
Today, only 1 out of 5,000 to 10,000 chemical compounds makes it to the pharmacy, and this process can take between eleven and…
Group Purchasing Organizations – Seriously Reviewed By GAO and Others
Last year Senator Charles Grassley (R-Iowa) asked for proof that the purchasing intermediaries that buy medical products for…
The Value of Medicine
A recent report from Eli Lilly focused on “The Value of Medicine,” and how pharmaceutical companies are dedicated to the discovery…
Healthcare Leadership Council: National Dialogue for Healthcare Innovation
Today, The Healthcare Leadership Council (HLC), a coalition of chief executives representing all sectors of American healthcare,…
MC Communications Proud of the Mission of Medical Education
Last week we wrote a commentary on a Boston Globe article that covered the start up of a continuing medical education publishing…
Forest Laboratories Settlement and Corporate Integrity Agreement
The Department of Justice (DOJ) announced that drug maker Forest Laboratories, Inc. has pleading guilty to resolve criminal…
Pharmaceutical Sponsored Talks Facilitates Two Way Communication on…
Over the past several years, and even more recently, academic medical centers have begun to “tighten restrictions on doctors…
Pharmaceutical Development Challenges Includes Deficit in Human Capital
Pharmaceutical development and discovery has faced significant challenges over the past several years. While the rate at which new…
Debate on Industry Research – Critic Admits to Mealy Mouthed Evidence
Critics Medical Researchers
Two groups—the "pharmapologists" and the “pharmascolds”—have long debated the proper role of the…